文献速递主动脉疾病

高危与复杂型B型主动脉夹层接受胸主动脉腔内修复术的结局

Outcomes of High Risk and Complicated Type B Aortic Dissections Treated with Thoracic Endovascular Aortic Repair.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2025-04-10

基于SVS VQI上市后研究2013至2023年641例数据,回顾性分析胸主动脉腔内修复术治疗复杂型B型主动脉夹层(cTBAD,191例)与高危型B型主动脉夹层(hrTBAD,450例)的结局。cTBAD组术后并发症更常见,30天、1年和5年生存率均低于hrTBAD组,再干预无差异。

要点

  • cTBAD组术后并发症比hrTBAD组更常见。
  • cTBAD组TEVAR术后30天、1年、5年生存率均低于hrTBAD组。
  • 两组再干预率无差异。

核心结论

  • 接受TEVAR的cTBAD患者围手术期和长期结局均差于hrTBAD患者。
  • 需要更多研究以阐明TEVAR对hrTBAD患者的长期获益。

研究设计与样本

  • 回顾性多中心SVS血管质量倡议(VQI)上市后研究(VQI PAS)数据分析。
  • 纳入2013年至2023年641例患者,按夹层急性程度分层:复杂型191例(cTBAD,定义为破裂或灌注不良),高危型450例(hrTBAD,定义为顽固性疼痛、顽固性高血压或主动脉直径≥40 mm)。

主要发现

  • 两组人口学特征和合并症相似。
  • cTBAD组中外院转入及术前肌酐≥1.8 mg/dL的患者比例更高。
  • cTBAD组术后并发症比hrTBAD组更常见。
  • Kaplan-Meier分析显示cTBAD组TEVAR术后30天、1年和5年生存率均低于hrTBAD组,但再干预无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Society for Vascular Surgery (SVS) and the Society for Thoracic Surgery published reporting standards defining complicated and uncomplicated type B aortic dissections (TBADs) and included previously undefined high risk features. This retrospective review of multi-institution SVS Vascular Quality Initiative (VQI) post-approval study (VQI PAS) data aimed to evaluate the outcomes of patients with high risk TBAD (hrTBAD) and complicated TBAD (cTBAD) treated with thoracic endovascular aortic repair (TEVAR). METHODS: The data of 641 patients collected from 2013 to 2023 were included. Patients were stratified by aortic dissection acuity: 191 complicated (cTBAD; defined as those with rupture or malperfusion) and 450 high risk (hrTBAD; defined as having refractory pain, refractory hypertension, or aortic diameter ≥ 40 mm). Uni- and multivariable analyses were used to determine the differences in outcomes by aortic dissection acuity for post-operative death, complications, and re-intervention. RESULTS: Demographics and comorbidities were similar between the groups. A higher proportion of patients within the cTBAD group were transferred from an outside facility and had a pre-operative creatinine ≥ 1.8 mg/dL. Post-operative complications were more common in the cTBAD group. On Kaplan-Meier analysis, there was a lower 30 day, one year, and five year survival after TEVAR in the cTBAD group, but without differences in re-intervention. CONCLUSION: Patients with cTBAD undergoing TEVAR have poorer peri-operative and long term outcomes compared with those with hrTBAD. More studies are necessary to better elucidate the implications and long term benefits of TEVAR for patients with hrTBAD.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Filiberto AC, Novak Z, Azizzadeh A, et al. Outcomes of High Risk and Complicated Type B Aortic Dissections Treated with Thoracic Endovascular Aortic Repair. Eur J Vasc Endovasc Surg. 2025. PMID: 40221079. doi:10.1016/j.ejvs.2025.04.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。